Business Description
Akeso Inc
ISIN : KYG0146B1032
Share Class Description:
HKSE:09926: Ordinary SharesCompare
Compare
Traded in other countries / regions
09926.Hong KongAKESF.USA4RY.Germany IPO Date
2020-04-24Description
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.64 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.64 | |||||
Debt-to-EBITDA | 1.38 | |||||
Interest Coverage | 24.91 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5.36 | |||||
Beneish M-Score | 0.99 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 8.3 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 35.8 | |||||
9-Day RSI | 39.98 | |||||
14-Day RSI | 41.15 | |||||
6-1 Month Momentum % | -2.21 | |||||
12-1 Month Momentum % | 10.09 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.71 | |||||
Quick Ratio | 4.39 | |||||
Cash Ratio | 4.06 | |||||
Days Inventory | 939.18 | |||||
Days Sales Outstanding | 22.06 | |||||
Days Payable | 858.82 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.2 | |||||
Shareholder Yield % | -3.68 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 97.06 | |||||
Operating Margin % | 47.87 | |||||
Net Margin % | 44.81 | |||||
FCF Margin % | 35.09 | |||||
ROE % | 48.46 | |||||
ROA % | 25.56 | |||||
ROIC % | 62.1 | |||||
ROC (Joel Greenblatt) % | 76.5 | |||||
ROCE % | 30.03 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 14.7 | |||||
PE Ratio without NRI | 15.08 | |||||
Price-to-Owner-Earnings | 15.33 | |||||
PS Ratio | 6.59 | |||||
PB Ratio | 6.38 | |||||
Price-to-Tangible-Book | 6.85 | |||||
Price-to-Free-Cash-Flow | 18.74 | |||||
Price-to-Operating-Cash-Flow | 12.04 | |||||
EV-to-EBIT | 13.32 | |||||
EV-to-Forward-EBIT | -71.01 | |||||
EV-to-EBITDA | 12.44 | |||||
EV-to-Revenue | 5.97 | |||||
EV-to-Forward-Revenue | 10.12 | |||||
EV-to-FCF | 17.64 | |||||
Price-to-Graham-Number | 2.14 | |||||
Price-to-Net-Current-Asset-Value | 25.26 | |||||
Price-to-Net-Cash | 73.4 | |||||
Earnings Yield (Greenblatt) % | 7.51 | |||||
FCF Yield % | 5.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Akeso Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 4,950.726 | ||
EPS (TTM) (HK$) | 2.647 | ||
Beta | 0.48 | ||
Volatility % | 47.64 | ||
14-Day RSI | 41.15 | ||
14-Day ATR (HK$) | 2.68253 | ||
20-Day SMA (HK$) | 38.7575 | ||
12-1 Month Momentum % | 10.09 | ||
52-Week Range (HK$) | 26.45 - 60 | ||
Shares Outstanding (Mil) | 865.86 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Akeso Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Akeso Inc Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Akeso Inc Frequently Asked Questions
What is Akeso Inc(HKSE:09926)'s stock price today?
The current price of HKSE:09926 is HK$38.90. The 52 week high of HKSE:09926 is HK$60.00 and 52 week low is HK$26.45.
When is next earnings date of Akeso Inc(HKSE:09926)?
The next earnings date of Akeso Inc(HKSE:09926) is 2024-09-26 Est..
Does Akeso Inc(HKSE:09926) pay dividends? If so, how much?
Akeso Inc(HKSE:09926) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |